Description:Nextech Invest is a renowned venture capital firm that specializes in global cancer therapeutics, with its headquarters located in Zurich, Switzerland. This firm is dedicated to the oncology sector, concentrating its efforts on fostering value creation for its portfolio companies. With a keen eye for innovation, Nextech Invest targets the most promising drug discovery companies that hold the potential to develop multiple groundbreaking medicines. Their investment strategy spans a broad geographical range, focusing on opportunities primarily within the United States and Europe. Nextech Invest participates in financing from the inception of companies all the way through to crossover rounds, showcasing their commitment to supporting the full lifecycle of impactful therapeutic developments in the fight against cancer.